MedPath

clinical study of efficacy of dadruvidravana Malahara in Dadru Kushtha(tinea corporis) in children

Phase 2/3
Not yet recruiting
Conditions
Infections of the skin and subcutaneous tissue. Ayurveda Condition: DADRU-KUSHTHAH,
Registration Number
CTRI/2023/11/059412
Lead Sponsor
Dr. Monika Sheshrao Adhave
Brief Summary

This study is  randomized ,open labelled, controlled, clinical study to evaluate the efficacy of dadruvidravana malahara in Dadru Kushtha.  Dadruvidravana Malahara  when applied locally as per requirement to the age group 4 years to 14 years twice in a day for 14 days, follow up on 15th day

this study will be carried out in 2 years of PG course

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 1)Patients selection will be irrespective of social economic status and gender.
    1. Patients of age group between 4 to 14 years.
    1. Parents willing for participation of their child and to give written consent.
Exclusion Criteria
  1. Patients having chronic infection of Dadru Kushtha more than 3 years 2) Patients having other skin diseases 3) Having major systemic diseases like HIV, Systemic Lupus Erythematous, tuberculosis etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the efficacy of Dadruvidravana Malahara when applied locally as per requirement to the age group 4 years to 14 years twice in a day for 14 daysDadruvidravana Malahara for local application for 14 days and assessment on 0 , 7th 15th day
Secondary Outcome Measures
NameTimeMethod
No anyNo

Trial Locations

Locations (1)

Government Ayurved College and Hospital,Nanded

🇮🇳

Nanded, MAHARASHTRA, India

Government Ayurved College and Hospital,Nanded
🇮🇳Nanded, MAHARASHTRA, India
DrMonika Sheshrao adhave
Principal investigator
08983550081
monikaadhave4@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.